The HIF-dependent upregulation of the urokinase plasminogen activator surface receptor (PLAUR) also increases the proteolytic activity of cancer cells, thereby altering the interaction between integrins and the ECM, promoting cell invasion [100–102]. Here, PLAUR is linked to cancer.